IBM (IBM) Stock Drops 13% as Anthropic Promotes a COBOL AI Tool

Posted on by

TLDRs;

  • After the AI startup Anthropic introduced Claude Code, IBM shares dropped by 13%, which triggered investors’ concerns about the risks of its legacy business.
  • Anthropic’s Claude Code tool automates the modernization of COBOL, a process that has traditionally demanded a great deal of manual coding work.
  • The market is worried that AI automation tools might reduce IBM’s mainframe revenue and impact its long – term growth prospects.
  • IBM’s mainframe operations are still crucial, serving financial institutions and governments that rely on COBOL applications.
  • IBM is facing the dual challenge of adapting to AI trends while maintaining the revenue streams of its legacy systems.

On February 23, IBM (IBM) witnessed its stock plunge by up to 13%, marking its most substantial intraday decline since March 2020. The sell – off is in response to comments and… from the AI startup Anthropic, which recently promoted its new Claude Code tool designed to modernize COBOL applications.

The sudden market reaction highlights the increasing concerns of investors about the impact of artificial intelligence on traditional technology companies, especially those relying on legacy systems. The declines in February have now pushed IBM’s monthly stock performance down by 26%, the steepest single – month drop for the company since at least 1968.

Claude Code Targets Legacy COBOL Systems

It is an AI – driven tool aimed at helping with the modernization of COBOL, a programming language that has powered IBM mainframes for decades. COBOL remains crucial in industries such as banking, insurance, and government operations, where legacy systems are the backbone of daily operations.

IBM Stock Card

According to Anthropic, Claude Code can automate parts of COBOL modernization, reducing the manual labor that has been historically required for such projects. While this has the potential to speed up software updates and system improvements, investors seem worried that widespread adoption could erode IBM’s long – standing competitive edge in the mainframe market.

Investor Concerns Over Legacy Business Impact

Most mainframe computers running COBOL are produced by IBM, making the company a central player in this specialized market. Analysts suggest that tools like Claude Code could threaten IBM’s revenue streams by allowing clients to modernize without relying as much on IBM’s mainframe services.

This concern has led to a rapid re – evaluation of IBM’s growth prospects. Investors are increasingly weighing the balance between IBM’s ongoing enterprise contracts and the potential disruption caused by emerging AI solutions that could make certain legacy services less essential.

Mainframe Business Still Holds Strategic Value

Despite the sell – off, IBM’s mainframe business continues to be a key pillar of its operations. Financial institutions, insurance companies, and government agencies still rely heavily on COBOL – based systems for core processes such as transaction processing, record – keeping, and regulatory compliance.

Industry experts note that even with AI – assisted modernization, transitioning away from legacy systems is complex and may not happen quickly. IBM still has a significant advantage in mainframe expertise, infrastructure, and support networks, which provides a buffer against short – term market volatility.

Looking Ahead: AI and Legacy Tech

The decline in IBM’s stock reflects a broader theme in technology investing: how AI innovations interact with established industries. While AI offers opportunities for efficiency and modernization, it also brings uncertainty for companies that have historically relied on specialized, slower – evolving technologies.

As AI tools like Claude Code gain popularity, IBM will need to show how it can use these technological changes to enhance, rather than undermine, its core offerings. The company’s ability to innovate while maintaining strong client relationships in critical sectors will be closely monitored by investors and analysts in the coming months.